Andere talen Bioretec Oy

Aandelen

BRETEC

FI4000480454

Beurs gesloten - Nasdaq Helsinki Andere beurzen 18:00:00 05-07-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
2,77 ^EUR	-3,48%		-3,82%	+15,42%

28/06	Bioretec meldt vertraging in ontvangst Europese CE-markering voor traumaschroef	MT
19/06	Bioretec Ltd. Rapporteert succesvolle klinische resultaten van de in de VS gecontroleerde lancering van de RemeOs Traumaschroef	CI

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

Bioretec Flags Delay in Receipt of European CE Mark for Trauma Screw	28/06
Inside Information: Update for Bioretec's RemeOs™ Trauma Screw European Marketing Authorization	27/06
Bioretec reports successful clinical outcomes from U.S. controlled launch of RemeOs™ trauma screw: fracture healing confirmed in 100% of surgical procedures	19/06
Bioretec Ltd. Reports Successful Clinical Outcomes from U.S. Controlled Launch of RemeOs Trauma Screw	19/06
Bioretec Appoints Frank Sarcone as Vice President of Sales for the US and a member of the Management Team	18/06
Notification in accordance with chapter 9, section 10 of the Securities Market Act on a change in holdings - Ilmarinen Mutual Pension Insurance Company	21/05
Medical Device Company Bioretec Names New CEO	21/05
Notification in accordance with chapter 9, section 10 of the Securities Market Act on a change in holdings (Stephen Industries Inc Oy)	20/05
Inside information: Alan Donze has been appointed as Bioretec's new CEO	20/05
Bioretec Ltd. Announces Transfer of Timo Lehtonen from CEO to Chief Technology Officer	20/05
Bioretec Ltd Announces CEO Changes	20/05
Bioretec Ltd's business review January-March 2024: Controlled launch in the U.S. progresses	16/05
Resolutions of Bioretec Ltd's Annual General Meeting and the constitutive meeting of the Board of Directors	26/04
Notice of Annual General Meeting (AGM) of Bioretec Ltd	08/04
Notice of Annual General Meeting (AGM) of Bioretec Ltd	05/04
Bioretec Oy Announces Pekka Simula Not Available for Re-Election to Board of Directors	05/04
Finland's Bioretec Gets US Patent Allowance for Magnesium Alloy Composition	22/03
Inside information: Bioretec's RemeOs™ biodegradable magnesium alloy composition has been allowed a patent by the U.S. Patent office	21/03
Bioretec Ltd. Receives a Patent by the U.S. Patent Office for its RemeOs Magnesium Alloy Composition	21/03
Bioretec Ltd's Annual Report and Financial Statements 2023 published	15/03

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Bioretec Oy

Aandelen

BRETEC

FI4000480454

Andere talen

Filters